REQUEST A DEMO
Total
USD $0.00
Search more companies

Intelligene Inc. (智新生技股份有限公司) (Taiwan, China)

Main Activities: Biological Product (except Diagnostic) Manufacturing | Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Intelligene Inc. Profile Updated: June 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Intelligene Inc. (智新生技股份有限公司) is based in Taiwan, China. The head office is in Taipei City. It operates in the Biological Product (except Diagnostic) Manufacturing industry. It was established on October 21, 2026. There was a total negative growth of 10.29% in Intelligene Inc. (智新生技股份有限公司)’s total assets over the same period.

Headquarters
14 F.-6, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Intelligene Inc. (智新生技股份有限公司) report to view the information.

Website: http://www.intelli-gene.com

Basic Information
Outstanding Shares:
Purchase the Intelligene Inc. (智新生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Intelligene Inc. (智新生技股份有限公司) report to view the information.
Incorporation Date:
October 21, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Subsidiaries
Intelligene Llc (United States)
100%
Intelligene Pty Ltd (Australia)
100%
Company Performance
Financial values in the chart are available after Intelligene Inc. (智新生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating Profit
-26.73%▼
EBITDA
-15.69%▼
Net Profit/Loss for the Period
37.96%▲
Total Assets
-10.29%▼
Total Equity
-10.49%▼
Return on Equity (ROE)
3.18%▲
Debt / Equity
-0.66%▼
Quick Ratio
-11.06%▼
Cash Ratio
-14.18%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?